FDA Recall Open, Classified

PANTHER FUSION System REF 9121010000 The Panther System is an integrated nucleic acid testing system which fully automates all steps necessary to perform Aptima assays from sample processing through amplification, detection, and data reduction. The Panther Fusion System is an integrated, fully automated, in vitro diagnostic (IVD) clinical multiplex test system. It is capable of performing nucleic acid based tests from sample processing through amplification, detection, and data reduction.

Recall: Z-0782-2024 · Initiated December 15, 2023

Recall

Recall Number
Z-0782-2024
Event Number
93593
Firm
Hologic, Inc.
FEI Number
2024800
Product Code
OOI
Status
Open, Classified
Root Cause
Under Investigation by firm
Initiated
December 15, 2023
Posted
January 23, 2024
Address
10210 Genetic Center Dr, San Diego, CA, 92121-4362

Description

PANTHER FUSION System REF 9121010000 The Panther System is an integrated nucleic acid testing system which fully automates all steps necessary to perform Aptima assays from sample processing through amplification, detection, and data reduction. The Panther Fusion System is an integrated, fully automated, in vitro diagnostic (IVD) clinical multiplex test system. It is capable of performing nucleic acid based tests from sample processing through amplification, detection, and data reduction.

Reason

Due to potential false positive Flu B results when a sample was also SARS-CoV-2 positive.

Action

On 12/15/2023, the firm send an "URGENT: MEDICAL DEVICE RECALL" Letter via FedEx 2-day delivery to customer informing them that the firm has became aware of potential erroneous influenza B virus (FLU B) positive results when testing with the Panther Fusion SARS-CoV-2/Flu A/B/RSV assay on the Panther Fusion System. Customers are instructed to: 1. They may continue to test with the Panther Fusion SARS-CoV-2/Flu A/B/RTSV assay on the Panther Fusion System. 2. Hologic has partnered with Novasyte, an IQVIA MedTech company, to assist in the recall. Acknowledge receipt of the notification by completing the Customer Acknowledgement Form located at https;//iqvia-response.my.site.com/mt/fca?cid=HPAN23 3. To ensure visibility of the issue, Hologic recommends posting the notification on or near the Panther Fusion Systems that are running the Panther Fusion SARS-CoV-2/Flu A/B/RSV assay. 4. If customers suspect a false Flu B positive result in combination with SARS-CoV-2 positive result (dual positive), contact Hologic Technical Support for evaluation and/or troubleshooting. For questions or assistance, contact Hologic Technical Support. Country-specific telephone and email contact information for Technical Support can be found at www.hologic.com/support.

Distribution

Worldwide - U.S. Nationwide distribution including in the states of AK, AR, CA, CO, CT, FL, IL, IN, MA, ME, MI, MN, MO, MT, NC, ND, NH, NJ, NM, NV, NY, OH, PA, Puerto Rico, TX, UT, VA, VI, WA, WI, and WV. The countries of Austria, Australia, Belgium, Dominican Republic, Switzerland, Germany, Denmark, Spain, France, Great Britain, Hong Kong, Ireland, Italy, Korea, Kuwait, The Netherlands, Norway, New Zealand, Portugal, Qatar, and Sweden.

Quantity

771 systems (of which 313 are potentially impacted)